ID: ALA4216584

Max Phase: Preclinical

Molecular Formula: C35H41Cl2N5O8S

Molecular Weight: 762.71

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(NC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO)c1ccc(OCc2cc(Cl)c(CN3CSC[C@H]3C(=O)N3CCN(C4CC4)c4ccccc43)cc2Cl)nc1

Standard InChI:  InChI=1S/C35H41Cl2N5O8S/c36-24-12-22(17-50-31-8-5-20(13-38-31)34(48)39-14-29(44)32(46)33(47)30(45)16-43)25(37)11-21(24)15-40-19-51-18-28(40)35(49)42-10-9-41(23-6-7-23)26-3-1-2-4-27(26)42/h1-5,8,11-13,23,28-30,32-33,43-47H,6-7,9-10,14-19H2,(H,39,48)/t28-,29-,30+,32+,33+/m0/s1

Standard InChI Key:  KALNGVGZRIWAOP-KVWIHSIESA-N

Associated Targets(Human)

G-protein coupled bile acid receptor 1 1723 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

G-protein coupled bile acid receptor 1 577 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mus musculus 284745 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 762.71Molecular Weight (Monoisotopic): 761.2053AlogP: 2.02#Rotatable Bonds: 14
Polar Surface Area: 179.16Molecular Species: NEUTRALHBA: 12HBD: 6
#RO5 Violations: 3HBA (Lipinski): 13HBD (Lipinski): 6#RO5 Violations (Lipinski): 3
CX Acidic pKa: 12.63CX Basic pKa: 3.55CX LogP: 1.59CX LogD: 1.59
Aromatic Rings: 3Heavy Atoms: 51QED Weighted: 0.14Np Likeness Score: -0.85

References

1. Chen T, Reich NW, Bell N, Finn PD, Rodriguez D, Kohler J, Kozuka K, He L, Spencer AG, Charmot D, Navre M, Carreras CW, Koo-McCoy S, Tabora J, Caldwell JS, Jacobs JW, Lewis JG..  (2018)  Design of Gut-Restricted Thiazolidine Agonists of G Protein-Coupled Bile Acid Receptor 1 (GPBAR1, TGR5).,  61  (17): [PMID:30141927] [10.1021/acs.jmedchem.8b00308]

Source